rhodioloside has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, L; Jiang, X; Peng, Z; Qiu, L; Xia, X; Yao, F; Zheng, W | 1 |
| Li, J; Liu, A; Liu, W; Liu, X; Wang, Y; Yu, H; Yu, S; Zuo, Z | 1 |
2 other study(ies) available for rhodioloside and Diabetic Retinopathy
| Article | Year |
|---|---|
Long-Term Oral Administration of Salidroside Alleviates Diabetic Retinopathy in db/db Mice.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucosides; Mice; Phenols | 2022 |
Salidroside Inhibits Ganglion Cell Apoptosis by Suppressing the Müller Cell Inflammatory Response in Diabetic Retinopathy.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Eosine Yellowish-(YS); Ependymoglial Cells; Glial Fibrillary Acidic Protein; Hematoxylin; Mice | 2023 |